Randox is proud to offer a growing range of novel quality control materials developed to support modern laboratories in achieving precision, accuracy, and traceability across rapidly evolving diagnostic landscapes.
These controls are specifically designed to complement emerging biomarkers used in oncology, inflammation, immunotherapy, and chronic disease research – making them ideal for clinical research and assay development.
To find out more about the Novel Controls or to get in touch with your local Randox Representative, enquire now.